Can You Take Zoloft While Pregnant? What to Know About Sertraline During Pregnancy

Deciding whether to take antidepressants during pregnancy is one of the most difficult choices expectant mothers face. Zoloft (sertraline) is one of the most commonly prescribed antidepressants, and many women wonder about its safety during pregnancy.

Untreated depression during pregnancy can carry significant risks for both mother and baby, making the decision to continue or start antidepressant treatment a careful balance of potential benefits and risks that should be made with your healthcare provider.

Key Takeaways

• Zoloft is not risk-free but may be necessary: Research suggests sertraline has a relatively favorable safety profile compared to other antidepressants, though no medication is completely without risk during pregnancy. The decision depends on balancing the risks of untreated depression against potential medication effects.

• Untreated depression poses serious risks: Maternal depression during pregnancy is associated with poor prenatal care, slower fetal development, preterm birth, low birth weight, and postpartum depression. For many women, the benefits of treatment outweigh the potential risks.

• Work closely with your healthcare team: Never stop or start Zoloft during pregnancy without medical guidance. Your doctor can help you weigh your individual situation, adjust dosing if needed, and monitor both your mental health and your baby's development.

What is Zoloft?

Zoloft (sertraline) is a selective serotonin reuptake inhibitor (SSRI) antidepressant approved by the FDA to treat depression, anxiety disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and other mental health conditions. SSRIs work by increasing serotonin levels in the brain, which helps regulate mood and emotional responses.

Perinatal depression is a mental health condition that affects individuals during pregnancy or up to one year after childbirth. With prevalence rates of around 10% in the general population, this condition is usually treated using therapy, antidepressants, or a combination of both. However, prescribing antidepressants during pregnancy is an individualized decision that must be taken by the healthcare provider after weighing the potential benefits vs risks.

This makes understanding the safety profile of medications like Zoloft critically important for maternal and fetal health.

Safety of Zoloft During Pregnancy

The safety of any medication during pregnancy is evaluated by examining available research, reported outcomes, and the FDA pregnancy category system. Understanding what research shows about Zoloft can help inform discussions with your healthcare provider.

What Research Shows

Multiple large studies have examined sertraline use during pregnancy with generally reassuring findings, though some risks have been identified:

No major heart defects: A large, population-based cohort study involving around 65,000 pregnant womenfound no increased risk of cardiac malformations associated with sertraline use during the first trimester. However, research continues to evaluate specific organ systems.

Slight risk for preeclampsia: A 2020 database study of over 15,000 pregnancies identified a small, dose-dependent increase in risk for preeclampsia (gestational hypertension) with exposure to SSRIs during pregnancy. However, underlying depression or anxiety may also contribute to this risk. 

No substantial risk of gestational diabetes: Recent studies on the risk of gestational diabetes with SSRI exposure show that SSRIs are not associated with a significant risk for gestational diabetes. 

Pregnancy complications: Some research suggests SSRI use may be associated with slightly increased rates of certain complications, such as an increased risk of preterm birth, decreased birth weight, and likelihood of NICU admission, though it's difficult to separate medication effects from the effects of untreated maternal depression itself. Even without treatment, people with depression are at increased risk of these adverse fetal and neonatal outcomes.

FDA Pregnancy Category

The FDA previously classified sertraline as Pregnancy Category C, meaning animal studies showed adverse effects, but adequate human studies are lacking. The FDA has since moved away from letter categories to more detailed pregnancy and lactation labeling that provides more nuanced information about risks and benefits.

Risks of Taking Zoloft During Early and Late Pregnancy

While many women safely take Zoloft throughout pregnancy, there are some potential risks to be aware of when making treatment decisions with your healthcare provider.

First Trimester Considerations

The first trimester is when the baby's organs are forming, making it the most critical period for potential medication effects. Research on first-trimester sertraline exposure has been relatively reassuring, though no medication can be declared completely risk-free.

Potential concerns include:

• Small increased risk of certain birth defects (though major studies have not consistently found this)

• Individual variations in sertraline metabolism during pregnancy exist, suggesting that medication dosage may need to be increased during pregnancy for the same therapeutic effect

Late Pregnancy Effects

Taking Zoloft during the third trimester has been associated with some temporary effects in newborns that typically resolve within two weeks:

Neonatal adaptation syndrome: Some babies exposed to SSRIs late in pregnancy may experience temporary symptoms after birth, including jitteriness, irritability, poor feeding, respiratory issues, or temperature regulation problems. According to research, low-dose sertraline exposure is associated with a doubling in the odds of delayed neonatal adaptation. However, these symptoms are generally mild and self-limiting. 

Persistent pulmonary hypertension: Some studies have suggested a potential link between late pregnancy SSRI use and persistent pulmonary hypertension of the newborn (PPHN), a serious but rare condition. A recent study suggests an absolute risk of PPHN of 0.18% in SSRI-exposed infants, with sertraline having the lowest risk.

Risks of Untreated Depression During Pregnancy

When considering whether to take Zoloft during pregnancy, it's essential to also understand the significant risks that untreated depression poses to both mother and baby.

Maternal Health Risks

Untreated depression during pregnancy can lead to:

• Poor prenatal care and nutrition

• Increased substance use (alcohol, tobacco, drugs)

• Higher risk of preeclampsia

• Increased risk of postpartum depression

• Thoughts of self-harm or suicide

Fetal and Infant Risks

According to ACOG guidelines, untreated maternal depression during pregnancy is associated with:

• Preterm birth and low birth weight; low Apgar scores

• Smaller head circumference

• Developmental delays in childhood

• Behavioral and emotional problems in children

• Difficulties with mother-infant bonding

Research published in JAMA Pediatrics found that children exposed to untreated maternal depression had poorer social-emotional, cognitive, language, motor, and adaptive behavior development.

When Zoloft May Be Recommended During Pregnancy

Healthcare providers carefully weigh individual circumstances when recommending whether to continue or start Zoloft during pregnancy.

Situations Where Benefits May Outweigh Risks

• Severe depression or anxiety: When symptoms significantly impair daily functioning, self-care, or prenatal care

• History of severe postpartum depression: Women with previous severe postpartum episodes may need continuous treatment

• Multiple failed treatment attempts: When depression hasn't responded to therapy alone or other interventions

• Suicidal thoughts: When there's risk of self-harm, treatment is typically essential

• Previous relapse after stopping medication: Women who became severely depressed after discontinuing antidepressants

Managing Zoloft Use During Pregnancy

If you and your healthcare provider decide that continuing or starting Zoloft during pregnancy is the best approach, several strategies can optimize safety and effectiveness.

Dosing Considerations

Pregnancy changes how your body processes medications. Some women need dose adjustments during pregnancy to maintain therapeutic effects, while others may be able to use lower doses. Your doctor will consider:

• Your current dose and symptom control

• Pregnancy-related changes in drug metabolism

• Side effects you're experiencing

• Previous response to dosage changes

Monitoring and Support

Regular monitoring throughout pregnancy is essential when taking Zoloft:

• Frequent mental health check-ins with your provider

• Monitoring for worsening depression or anxiety

• Assessment of medication side effects

• Coordination between your obstetrician and mental health provider

• Ultrasounds and fetal monitoring as recommended

• Planning for postpartum period and breastfeeding

Never Stop Abruptly

Suddenly stopping Zoloft can cause withdrawal symptoms and may lead to a rapid return of depression symptoms. If you and your doctor decide to discontinue Zoloft, it should be tapered gradually under medical supervision.

Zoloft and Breastfeeding

Many women who take Zoloft during pregnancy wonder about continuing the medication while breastfeeding. Research on sertraline and breastfeeding is generally reassuring.

According to the National Institutes of Health LactMed database, sertraline passes into breast milk in very small amounts. Studies measuring sertraline levels in breastfed infants found either undetectable levels or extremely low concentrations. The American Academy of Pediatrics considers sertraline compatible with breastfeeding.

Experts commonly consider sertraline one of the preferred antidepressants during breastfeeding due to its low blood level in infants. However, you should still discuss the decision with your healthcare provider and monitor your baby for any unusual symptoms.

Having the Conversation with Your Healthcare Provider

Discussing antidepressant use during pregnancy requires open, honest communication with your healthcare team. Prepare for these conversations by:

Questions to Ask Your Doctor

• What are the specific risks and benefits for my situation?

• Are there alternatives to medication that might work for me?

• How will my mental health be monitored during pregnancy?

• What dose is appropriate during pregnancy?

• What signs should I watch for in myself and my baby?

• What's the plan for the postpartum period?

Information to Share

Be prepared to discuss:

• Your complete mental health history

• Previous responses to medications and therapy

• Severity of current symptoms

• Your support system and resources

• Any history of postpartum depression

• Other medications or supplements you're taking

Getting Mental Health Support During Pregnancy

Whether or not you take Zoloft during pregnancy, accessing comprehensive mental health support is essential for your well-being and your baby's health.

Blossom Health offers virtual psychiatric care specifically designed for busy parents and expectant mothers. Our board-certified psychiatrists provide comprehensive medication management and treatment planning through convenient telehealth appointments, all covered by in-network insurance. You can schedule an appointment within days and receive expert guidance about medication use during pregnancy and postpartum. Learn more about getting started.

Other resources include:

• Pregnancy-focused therapists and support groups

• Perinatal mental health specialists

• Your obstetrician's mental health recommendations

• Community mental health centers

• The National Maternal Mental Health Hotline: 1-833-943-5746

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Decisions about medication use during pregnancy are highly individual and should be made in consultation with qualified healthcare providers who know your complete medical history. Never start, stop, or change psychiatric medications during pregnancy without medical supervision. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.

Sources

1. Jahan, N., Went, T. R., Sultan, W., Sapkota, A., Khurshid, H., Qureshi, I. A., & Alfonso, M. (2021). Untreated Depression During Pregnancy and Its Effect on Pregnancy Outcomes: A Systematic Review. Cureus, 13(8), e17251. https://pmc.ncbi.nlm.nih.gov/articles/PMC8448270 

2. Viatris Inc. (2023). Zoloft (sertraline hydrochloride) tablets and oral solution: Prescribing information (Revised August 2023). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf 

3. National Institute of Mental Health. (n.d.). Perinatal depression. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/publications/perinatal-depression

4. Payne, J. L., & Meltzer-Brody, S. (2009). Antidepressant use during pregnancy: current controversies and treatment strategies. Clinical obstetrics and gynecology, 52(3), 469–482.              https://pmc.ncbi.nlm.nih.gov/articles/PMC2749677/ 

5. Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant Use in Pregnancy and the Risk of Cardiac Defects. N Engl J Med. 2014;370(25):2397-2407. https://www.nejm.org/doi/full/10.1056/NEJMoa1312828 

6. Palmsten, K., Chambers, C. D., Wells, A., & Bandoli, G. (2020). Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatric and perinatal epidemiology, 34(5), 597–606. https://pmc.ncbi.nlm.nih.gov/articles/PMC7819597/ 

7. Lupattelli, A., Barone-Adesi, F., & Nordeng, H. (2022). Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study. Pharmacoepidemiology and drug safety, 31(2), 247–256.                                     https://pubmed.ncbi.nlm.nih.gov/34817916/ 

8. Lebin, L. G., & Novick, A. M. (2022). Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child. Current psychiatry reports, 24(11), 687–695. https://pmc.ncbi.nlm.nih.gov/articles/PMC10590209/ 

9. Shen, Z.-Q., Gao, S.-Y., Li, S.-X., et al. (2017). Sertraline use in the first trimester and risk of congenital anomalies: A systematic review and meta-analysis of cohort studies. British Journal of Clinical Pharmacology, 83(4), 909–922.                             https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.13161 

10. Yue, Q. Y., Borobia, A. M., Polasek, T. M., & Mangoni, A. A. (2023). Pharmacokinetics of antidepressants in pregnancy. Journal of Clinical Pharmacology, 63(7), 773–787. https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2282 

11. Cornet, M. C., Wu, Y. W., Forquer, H., Avalos, L. A., Sriram, A., Scheffler, A. W., Newman, T. B., & Kuzniewicz, M. W. (2024). Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study. Archives of disease in childhood. Fetal and neonatal edition, 109(3), 294–300 https://pmc.ncbi.nlm.nih.gov/articles/PMC11041605/ 

12. Ng, Q. X., Venkatanarayanan, N., Ho, C. Y. X., Sim, W. S., Lim, D. Y., & Yeo, W. S. (2019). Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis. Journal of women's health (2002), 28(3), 331–338.              https://pubmed.ncbi.nlm.nih.gov/30407100/ 

13. Vlenterie, R., van Gelder, M. M. H. J., Anderson, H. R., Andersson, L., et al. (2021). Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis. Obstetrics and Gynecology, 138(4), 633–646. https://pubmed.ncbi.nlm.nih.gov/34623076/ 

14. Yonkers, K. A., Wisner, K. L., Stewart, D. E., et al. (2009). The management of depression during pregnancy: A report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry, 31(5), 403–413. https://www.sciencedirect.com/science/article/abs/pii/S0163834309000619 

15. Armstrong, C. (2008). ACOG guidelines on psychiatric medication use during pregnancy and lactation. American Family Physician, 78(6), 772-778. https://www.aafp.org/pubs/afp/issues/2008/0915/p772.html 

16. Rogers, A., Obst, S., Teague, S. J. (2020). Association Between Maternal Perinatal Depression and Anxiety and Child and Adolescent Development: A Meta-analysis. 174;(11):1082-1092.   https://jamanetwork.com/journals/jamapediatrics/fullarticle/2770120 

17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Sertraline. [Updated 2025 Dec 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501191/ 

18. Centers for Disease Control and Prevention. (2024, May 15). Depression during and after pregnancy. U.S. Department of Health and Human Services. https://www.cdc.gov/reproductivehealth/features/maternal-depression/index.html

19. American Psychiatric Association. (n.d.). What is postpartum depression? Retrieved from: https://www.psychiatry.org/patients-families/postpartum-depression/what-is-postpartum-depression